Key facts
- It has raised $26.3M; the latest was Later Stage VC in Oct 2024.
- Notable investors include Tech Incubator Program for Startup, MedTech Innovator, SparkLabs Group, Partners Investment, CJ Investment — 9 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for Waycen
- ·The full record, as it builds
Funding rounds
No funding rounds for Waycen are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Waycen
Developer of medical artificial intelligence devices designed for health management, disease prevention and treatment strategy. The company specializes in medical big data collection, processing and gene mutation analysis, enabling medical practitioners to analyze endoscopic images in real-time and providing key information to medical staff.
- Sector
- Healthcare
- HQ
- Seoul, South Korea
- Founded
- 2019
- Employees
- 25
- Website
- waycen.com/
- Ownership
- Privately Held (backing)
Waycen doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Waycen shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Waycen in its N-PORT filings yet. We sweep new filings monthly.